We are live on ! Find out more

503 hedge funds and large institutions have $18.7B invested in Incyte in 2017 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 190 increasing their positions, 179 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 72

1.89% more ownership

Funds ownership: 91.95%93.84% (+1.9%)

1% more funds holding

Funds holding: 496503 (+7)

6% more repeat investments, than reductions

Existing positions increased: 190 | Existing positions reduced: 179

14% less funds holding in top 10

Funds holding in top 10: 1412 (-2)

17% less capital invested

Capital invested by funds: $22.6B → $18.7B (-$3.86B)

33% less call options, than puts

Call options by funds: $213M | Put options by funds: $316M

Holders
503
Holders Change
+7
Holders Change %
+1.41%
% of All Funds
11.41%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.27%
New
82
Increased
190
Reduced
179
Closed
72
Calls
$213M
Puts
$316M
Net Calls
-$103M
Net Calls Change
-$12.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Calamos Advisors
226
Calamos Advisors
Illinois
$2.08M -$10.5M -100,745 -82%
NAM
227
Nissay Asset Management
Japan
$2.08M +$2.29M +21,901 New
HighTower Advisors
228
HighTower Advisors
Illinois
$2.07M +$409K +3,916 +22%
CG
229
Cutler Group
California
$2.02M +$1.95M +18,704 +720%
CGH
230
Crossmark Global Holdings
Texas
$2.01M +$29.6K +283 +1%
VIA
231
Vident Investment Advisory
Georgia
$1.99M +$858K +8,205 +84%
T
232
TOBAM
France
$1.96M +$2M +19,153 +1,270%
KBC Group
233
KBC Group
Belgium
$1.93M -$217K -2,078 -9%
AC
234
Argentiere Capital
Switzerland
$1.89M -$2.61M -25,000 -56%
SOADOR
235
State of Alaska Department of Revenue
Alaska
$1.87M +$1.19M +11,351 +135%
FIM
236
Freedom Investment Management
Connecticut
$1.84M -$208K -1,993 -9%
M&T Bank
237
M&T Bank
New York
$1.84M -$197K -1,881 -9%
SAM
238
Shikiar Asset Management
New York
$1.78M -$1.2M -11,500 -38%
Public Sector Pension Investment Board (PSP Investments)
239
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.78M +$19K +182 +1%
TRSOTSOK
240
Teachers Retirement System of the State of Kentucky
Kentucky
$1.78M -$8.51M -81,421 -81%
AIM
241
Assured Investment Management
New York
$1.75M -$3.72M -35,630 -66%
OPPM
242
Opus Point Partners Management
New York
$1.74M -$191K -1,830 -9%
OPERF
243
Oregon Public Employees Retirement Fund
Oregon
$1.73M +$20.9K +200 +1%
SAM
244
Securian Asset Management
Minnesota
$1.7M +$69.4K +664 +4%
Mirae Asset Global Investments
245
Mirae Asset Global Investments
South Korea
$1.68M +$228K +2,180 +14%
Creative Planning
246
Creative Planning
Kansas
$1.67M +$434K +4,152 +31%
CSS
247
Cubist Systematic Strategies
Connecticut
$1.67M +$1.44M +13,755 +358%
NIPH
248
NN Investment Partners Holdings
Netherlands
$1.66M
SCM
249
Shelton Capital Management
Colorado
$1.63M -$10.6K -101 -0.6%
DILIC
250
Dai-ichi Life Insurance Company
Japan
$1.62M -$4.57M -43,765 -72%

INCY Hedge Fund Activity: Q4 2017 in Review

503 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q4 2017, worth a combined $18.7B — down 17% from $22.6B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new INCY positions and 72 closed out — a net gain of 10 holders — while 190 added to existing stakes and 179 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $739M. The largest seller was OrbiMed, exiting entirely with an estimated $172M sold.

  • 503 institutional investors held Incyte (INCY) as of Q4 2017, up from 496 in Q3 2017.
  • Funds reported $18.7B of Incyte stock for Q4 2017, down 17% quarter-over-quarter.
  • 82 funds opened new Incyte positions in Q4 2017 and 72 closed out, a net change of +10 holders.
  • The largest Incyte buyer in Q4 2017 was T. Rowe Price Associates, an estimated $739M added.
  • The largest Incyte seller in Q4 2017 was OrbiMed, an estimated $172M sold.

Based on aggregated 13F filings for Q4 2017.